A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice

Vaccine

Volumn 30, Issue 20, 2012, Pages 3047-3052

  Tierney, Rob ^a   Nakai, Toru ^b,c   Parkins, Christopher J ^b   Caposio, Patrizia ^b   Fairweather, Neil F ^d   Sesardic, Dorothea ^a   Jarvis, Michael A ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c ASTELLAS PHARMA INC   (Japan)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody; Cytomegalovirus based vaccine; Mice; Neglected tropical disease; Tetanus

Indexed keywords

MOUSE CYTOMEGALOVIRUS BASED TETANUS VACCINE; TETANUS ANTIBODY; TETANUS TOXIN; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CLOSTRIDIUM TETANI; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONSTRUCT; GENETIC CODE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE DRUG DOSE; TETANUS; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; ANTITOXINS; CYTOMEGALOVIRUS; DISEASE MODELS, ANIMAL; GENETIC VECTORS; MICE; PEPTIDE FRAGMENTS; TETANUS; TETANUS TOXIN; TETANUS TOXOID;

EID: 84859431799     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.043     Document Type: Article

References (23)

1. Farrar J.J., Yen L.M., Cook T., Fairweather N., Binh N., Parry J., et al. Tetanus. J Neurol Neurosurg Psychiatry 2000, 69:292-301.
2. Roper M.H., Vandelaer J.H., Gasse F.L. Maternal and neonatal tetanus. Lancet 2007, 370:1947-1959.
3. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375:1969-1987.
4. Tsuda Y., Caposio P., Parkins C.J., Botto S., Messaoudi I., Cicin-Sain L., et al. A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus. PLoS Negl Trop Dis 2011, 5:e1275.
5. Hansen S.G., Ford J.C., Lewis M.S., Ventura A.B., Hughes C.M., Coyne-Johnson L., et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 2011, 473:523-527.
6. Lloyd M.L., Shellam G.R., Papadimitriou J.M., Lawson M.A. Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3. Biol Reprod 2003, 68:2024-2032.
7. Smith L.M., Lloyd M.L., Harvey N.L., Redwood A.J., Lawson M.A., Shellam G.R. Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vector. Vaccine 2005, 23:2959-2969.
8. Lloyd M.L., Papadimitriou J.M., O'Leary S., Robertson S.A., Shellam G.R. Immunoglobulin to zona pellucida 3 mediates ovarian damage and infertility after contraceptive vaccination in mice. J Autoimmunity 2010, 35:77-85.
9. Maninger S., Bosse J.B., Lemnitzer F., Pogoda M., Mohr C.A., von Einem J., et al. M94 is essential for the secondary envelopment of murine cytomegalovirus. J Virol 2011, 85:9254-9267.
10. Snyder C.M., Cho K.S., Bonnett E.L., Allan J.E., Hill A.B. Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog 2011, 7:e1002295.
11. Wagner M., Jonjic S., Koszinowski U.H., Messerle M. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 1999, 73:7056-7060.
12. Makoff A.J., Oxer M.D., Romanos M.A., Fairweather N.F., Ballantine S. Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. Nucleic Acids Res 1989, 17:10191-10202.
13. Uetsuki T., Naito A., Nagata S., Kaziro Y. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha. J Biol Chem 1989, 264:5791-5798.
14. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
15. Zurbriggen R., Gluck R. Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice. Vaccine 1999, 17:1301-1305.
16. Mazzantini R.P., Miyaji E.N., Dias W.O., Sakauchi D., Nascimento A.L., Raw I., et al. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C. Vaccine 2004, 22:740-746.
17. Tregoning J.S., Clare S., Bowe F., Edwards L., Fairweather N., Qazi O., et al. Protection against tetanus toxin using a plant-based vaccine. Eur J Immunol 2005, 35:1320-1326.
18. Hansen S.G., Vieville C., Whizin N., Coyne-Johnson L., Siess D.C., Drummond D.D., et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 2009, 15:293-299.
19. Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005, 202:673-685.
20. Kenneson A., Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17:253-276.
21. Cannon M.J., Schmid D.S., Hyde T.B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010, 20:202-213.
22. Hansen S.G., Powers C.J., Richards R., Ventura A.B., Ford J.C., Siess D., et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 2010, 328:102-106.
23. Ross S.A., Arora N., Novak Z., Fowler K.B., Britt W.J., Boppana S.B. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 2010, 201:386-389.